Successes and failures with 670G
Training and patient selection for the artificial pancreas
Abstract
Background and Aims / Part 1
There is increasing evidence of both glycaemic and quality of life benefits of hybrid closed-loop systems in the management of type 1 diabetes. Commercially available hybrid closed-loop systems are increasingly being used as part of routine clinical diabetes care.
In order for the potential benefits of closed-loop systems to be realised by users, effective training and support of both users and healthcare providers is critical. Different closed-loop systems incorporate different algorithms with varying modifiable settings and additional features. Interaction with and usability of each closed-loop system will also vary, and will largely determine user satisfaction and therefore potential clinical benefit.
In this talk we report on our extensive experience of training and supporting users of all ages, from very young children (and their carers) to older adults over the age of 60 years with type 1 diabetes, on closed-loop systems. We will also discuss key considerations for training healthcare providers on training and supporting others to use closed-loop systems most effectively.
What do the patients think of artificial pancreas?
Abstract
Background and Aims / Part 1
Automated insulin delivery systems represent cutting edge technologies aimed at improving glycaemic control. With varying levels of interaction required across different systems, this lecture will explore facilitators and barriers to effective engagement with automated insulin delivery systems from both research and user perspectives
Methods
Mixed methods approach to understanding the hopes, anxieties, experience and unmet needs related to automated insulin delivery systems. Quantitative and qualitative data will be presented from our program of research into the lived experience and psychosocial aspects of automated insulin delivery systems for users and HCPs.
Methods / Part 2
Mixed methods approach to understanding the hopes, anxieties, experience and unmet needs related to automated insulin delivery systems. Quantitative and qualitative data will be presented from our program of research into the lived experience and psychosocial aspects of automated insulin delivery systems for users and HCPs.Results / Part 3
Results will be presented reporting qualitative interviews and additional data. Data from different key stakeholder perspectives, i.e. adults, children, parents and partners living with Type 1 diabetes as well as healthcare professionals.Results
Results will be presented reporting qualitative interviews and additional data. Data from different key stakeholder perspectives, i.e. adults, children, parents and partners living with Type 1 diabetes as well as healthcare professionals.
Conclusions / Part 4
Results will be discussed in the context of personalised diabetes management, individualised needs and challenges posed. Unmet needs will be examined in the context of healthcare delivery and support required by healthcare professionals and people living with diabetes.Conclusions
Results will be discussed in the context of personalised diabetes management, individualised needs and challenges posed. Unmet needs will be examined in the context of healthcare delivery and support required by healthcare professionals and people living with diabetes.